Attached files
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 8, 2021 (March 3, 2021)
Altimar Acquisition Corp. III
(Exact name of registrant as specified in its charter)
| Cayman Islands | 001-40149 | 98-1576586 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
40 West 57th Street
33rd Floor
New York, New York 10019
(Address of principal executive offices, including zip code)
(212) 287-6767
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant |
ATAQ.U | New York Stock Exchange | ||
| Class A ordinary share, $0.0001 par value | ATAQ | New York Stock Exchange | ||
| Warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share | ATAQ WS | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On March 8, 2021, Altimar Acquisition Corp. III (the “Company”) consummated its initial public offering (the “IPO”) of 15,525,000 units (the “Units”), including the issuance of 2,025,000 Units as a result of the underwriters’ exercise of their over-allotment option in full. Each Unit consists of one share of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Class A Ordinary Share”), and one-fourth of one redeemable warrant of the Company (each whole warrant, a “Warrant”), with each whole warrant entitling the holder thereof to purchase one whole Class A Ordinary Share at a price of $11.50 per share, subject to adjustment as provided in the Company’s registration statement on Form S-1, initially filed with the Securities and Exchange Commission on January 29, 2021 (File No. 333-252570) (as amended, the “Registration Statement”). The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $155,250,000.
In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement:
| • | an underwriting agreement, dated March 3, 2021, by and among the Company, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters named therein, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference; |
| • | a warrant agreement, dated as of March 3, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference; |
| • | an investment management trust agreement, dated as of March 3, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference; |
| • | a registration and shareholder rights agreement, dated as of March 3, 2021, by and among the Company, the Company’s sponsor, Altimar Sponsor III, LLC (the “Sponsor”), and certain other security holders named therein, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference; |
| • | a private placement warrants purchase agreement, dated as of March 3, 2021, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference; |
| • | a letter agreement, dated March 3, 2021 (the “Letter Agreement”), by and among the Company, the Sponsor and its executive officers and directors, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference; |
| • | an administrative support agreement, dated as of March 3, 2021, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference; |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Tom Wasserman, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference; |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Wendy Lai, a copy of which is attached as Exhibit 10.7 hereto and incorporated herein by reference; |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Payne D. Brown, a copy of which is attached as Exhibit 10.8 hereto and incorporated herein by reference; |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Richard M. Jelinek, a copy of which is attached as Exhibit 10.9 hereto and incorporated herein by reference; |
2
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Roma Khanna, a copy of which is attached as Exhibit 10.10 hereto and incorporated herein by reference; |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Michael Rubenstein, a copy of which is attached as Exhibit 10.11 hereto and incorporated herein by reference; |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Vijay K. Sondhi, a copy of which is attached as Exhibit 10.12 hereto and incorporated herein by reference; and |
| • | an indemnification agreement, dated as of March 3, 2021, by and between the Company and Michael Vorhaus, a copy of which is attached as Exhibit 10.13 hereto and incorporated herein by reference. |
Item 3.02 Unregistered Sales of Equity Securities.
Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 6,105,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $6,105,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the IPO, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Warrants (except to certain permitted transferees) until thirty (30) days after the completion of the Company’s initial business combination. The Private Placement Warrants are also not redeemable by the Company so long as they are held by the Sponsor or its permitted transferees. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 3, 2021, in connection with the IPO, Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus were appointed to the board of directors of the Company (the “Board”). Each of Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus is an independent director. Effective March 3, 2021, Mr. Jelinek, Mr. Rubenstein and Mr. Vorhaus were appointed to the Audit Committee of the Board, with Mr. Jelinek serving as the chair of the Audit Committee. Effective March 3, 2021, Mr. Brown, Mr. Jelinek and Mr. Sondhi were appointed to the Compensation Committee of the Board, with Mr. Brown serving as the chair of the Compensation Committee. Effective March 3, 2021, Mr. Brown, Ms. Khanna and Mr. Rubenstein were appointed to the Nominating Committee of the Board, with Mr. Brown serving as the chair of the Nominating Committee.
Following the appointment of Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus, the Board is comprised of the following three classes: (i) the term of office of the first class of directors, consisting of Mr. Brown and Mr. Jelinek, will expire at the Company’s first annual meeting of shareholders; (ii) the term of office of the second class of directors, consisting of Ms. Khanna and Mr. Rubenstein, will expire at the Company’s second annual meeting of shareholders; and (iii) the term of office of the third class of directors, consisting of Mr. Sondhi, Mr. Vorhaus and Mr. Wasserman, will expire at the Company’s third annual meeting of shareholders.
On March 3, 2021, in connection with their appointments to the Board, each of Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus entered into the Letter Agreement as well as an indemnity agreement with the Company. In addition, on January 28, 2021, the Sponsor transferred 10,000 Class B ordinary shares, par value $0.0001, of the Company to each of Mr. Brown, Mr. Jelinek, Ms. Khanna, Mr. Rubenstein, Mr. Sondhi and Mr. Vorhaus.
Other than the foregoing, none of the directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and indemnity agreements do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and the indemnity agreements, copies of which are attached as Exhibit 10.4 and 10.8 through 10.13 hereto and incorporated herein by reference.
3
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On March 3, 2021, in connection with the IPO, the Company adopted the amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”), effective the same date, which both amends and restates the provisions of the memorandum and articles of association of the Company. A copy of the Amended and Restated Memorandum and Articles of Association is attached as Exhibit 3.1 hereto and incorporated herein by reference.
Item 8.01 Other Events.
A total of $155,250,000, which amount includes $5,433,750 of the underwriters’ deferred discount, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes, if any, and up to $100,000 of interest to pay dissolution expenses, the proceeds from the IPO and the sale of the Private Placement Warrants held in the trust account will not be released from the trust account (1) to the Company, until the completion of the Company’s initial business combination or (2) to the Company’s public shareholders, until the earliest of (a) the completion of the Company’s initial business combination, and then only in connection with the Class A Ordinary Shares that the Company’s public shareholders properly elected to redeem, subject to the limitations described in the Registration Statement, (b) the redemption of the public Class A Ordinary Shares properly tendered in connection with a shareholder vote to amend the Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to provide holders of the Class A Ordinary Shares the right to have their the Class A Ordinary Shares redeemed in connection with the Company’s initial business combination or to redeem 100% of the public Class A Ordinary Shares if the Company does not complete its initial business combination within twenty-four (24) months from the closing of the IPO or (B) with respect to any other provision relating to the rights of holders of the Class A Ordinary Shares, and (c) the redemption of the public Class A Ordinary Shares if the Company has not consummated its business combination within twenty-four (24) months from the closing of the IPO, subject to applicable law.
On March 4, 2021, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.
On March 8, 2021, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
EXHIBIT INDEX
4
5
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ALTIMAR ACQUISITION CORP. III | ||||||
| Date: March 8, 2021 | By: | /s/ Wendy Lai | ||||
| Name: Wendy Lai | ||||||
| Title: Chief Financial Officer | ||||||
6